Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

Daniel B Yarosh1, Arely V Pena, Stephanie L Nay

  • 1Applied Genetics Inc. Dermatics, Freeport, New York 11520, USA. danyarosh@agiderm.com

Insights

Calcineurin inhibitors, like cyclosporine A, impair DNA repair and apoptosis in skin cells after UVB exposure, increasing skin cancer risk in transplant patients. This local effect complements systemic immune suppression.

Area of Science:

  • Dermatology
  • Immunology
  • Molecular Biology

Background:

  • Solid organ transplantation frequently involves calcineurin inhibitors (CNIs).
  • CNIs are associated with an elevated risk of skin cancer in transplant recipients.
  • The precise mechanisms underlying this increased skin cancer risk are not fully understood.

Purpose of the Study:

  • To investigate the impact of CNIs on DNA repair and apoptosis in human keratinocytes following ultraviolet B (UVB) irradiation.
  • To explore the effect of CNIs on the nuclear translocation of nuclear factor of activated T-cells (NFAT) in response to UVB.

Main Methods:

  • Normal human keratinocytes were irradiated with UVB.
  • The removal of cyclobutane pyrimidine dimers (CPDs) was assessed.
  • UVB-induced apoptosis was measured.
  • Nuclear localization of NFAT was analyzed in the presence and absence of CNIs.

Main Results:

  • Cyclosporine A (CsA) and ascomycin significantly inhibited the removal of CPDs.
  • Both CNIs suppressed UVB-induced apoptosis in keratinocytes.
  • UVB-induced nuclear translocation of NFAT was blocked by CsA and ascomycin.

Conclusions:

  • CNIs may increase skin cancer risk in organ transplant patients through local inhibition of DNA repair and apoptosis in skin, in addition to systemic immune suppression.
  • These findings suggest potential risks associated with topical CNI use on sun-exposed skin and eyes.

Related Concept Videos

Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...